Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 496

1.

Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.

Kim H, Yoo JE, Cho JY, Oh BK, Yoon YS, Han HS, Lee HS, Jang JJ, Jeong SH, Kim JW, Park YN.

J Hepatol. 2013 Oct;59(4):746-52. doi: 10.1016/j.jhep.2013.05.011. Epub 2013 May 14.

PMID:
23685049
2.

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.

Kim H, Choi GH, Na DC, Ahn EY, Kim GI, Lee JE, Cho JY, Yoo JE, Choi JS, Park YN.

Hepatology. 2011 Nov;54(5):1707-17. doi: 10.1002/hep.24559.

PMID:
22045674
3.

Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.

Nahm JH, Kim H, Lee H, Cho JY, Choi YR, Yoon YS, Han HS, Park YN.

Tumour Biol. 2016 Jan;37(1):393-403. doi: 10.1007/s13277-015-3810-7. Epub 2015 Jul 29.

PMID:
26219896
4.

TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.

Frescas D, de Lange T.

Mol Cell Biol. 2014 Apr;34(7):1349-62. doi: 10.1128/MCB.01052-13. Epub 2014 Jan 27.

5.

Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.

Butler KS, Hines WC, Heaphy CM, Griffith JK.

Cancer Med. 2012 Oct;1(2):165-75. doi: 10.1002/cam4.14. Epub 2012 Jul 24.

6.

Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma.

Kim GJ, Kim H, Park YN.

PLoS One. 2013 Sep 24;8(9):e75449. doi: 10.1371/journal.pone.0075449. eCollection 2013.

7.

Hepatocellular carcinomas expressing 'stemness'-related markers: clinicopathological characteristics.

Kim H, Park YN.

Dig Dis. 2014;32(6):778-85. doi: 10.1159/000368021. Epub 2014 Oct 29. Review.

PMID:
25376296
8.

Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization.

Rhee H, Nahm JH, Kim H, Choi GH, Yoo JE, Lee HS, Koh MJ, Park YN.

Mod Pathol. 2016 Sep;29(9):1038-49. doi: 10.1038/modpathol.2016.111. Epub 2016 Jun 17.

9.

In vivo stoichiometry of shelterin components.

Takai KK, Hooper S, Blackwood S, Gandhi R, de Lange T.

J Biol Chem. 2010 Jan 8;285(2):1457-67. doi: 10.1074/jbc.M109.038026. Epub 2009 Oct 28.

10.

High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.

Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim KS, Lee JJ, Park C.

Lab Invest. 2008 Feb;88(2):144-52. Epub 2007 Dec 24.

11.

Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma.

Chan AW, Tong JH, Chan SL, Lai PB, To KF.

Histopathology. 2014 Jun;64(7):935-50. doi: 10.1111/his.12342. Epub 2014 Feb 7.

PMID:
24506513
12.

Cause-specific telomere factors deregulation in hepatocellular carcinoma.

El Idrissi M, Hervieu V, Merle P, Mortreux F, Wattel E.

J Exp Clin Cancer Res. 2013 Sep 11;32:64. doi: 10.1186/1756-9966-32-64.

13.

Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.

Lee JE, Oh BK, Choi J, Park YN.

Int J Cancer. 2008 Jul 15;123(2):264-272. doi: 10.1002/ijc.23376.

14.

Shelterin: the protein complex that shapes and safeguards human telomeres.

de Lange T.

Genes Dev. 2005 Sep 15;19(18):2100-10. Review.

15.

TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.

Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O'Connor MS, Songyang Z.

Nature. 2007 Feb 1;445(7127):559-62. Epub 2007 Jan 21.

PMID:
17237767
16.

TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres.

Ye JZ, Donigian JR, van Overbeek M, Loayza D, Luo Y, Krutchinsky AN, Chait BT, de Lange T.

J Biol Chem. 2004 Nov 5;279(45):47264-71. Epub 2004 Aug 16.

17.

Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.

Matsutani N, Yokozaki H, Tahara E, Tahara H, Kuniyasu H, Haruma K, Chayama K, Yasui W, Tahara E.

Int J Oncol. 2001 Sep;19(3):507-12.

PMID:
11494028
18.

MRI features of hepatocellular carcinoma expressing progenitor cell markers.

Jeong HT, Kim MJ, Kim YE, Park YN, Choi GH, Choi JS.

Liver Int. 2012 Mar;32(3):430-40. doi: 10.1111/j.1478-3231.2011.02640.x. Epub 2011 Sep 13.

PMID:
22097930
19.

Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation.

Nishikawa T, Nakajima T, Katagishi T, Okada Y, Jo M, Kagawa K, Okanoue T, Itoh Y, Yoshikawa T.

Liver Int. 2009 Jul;29(6):846-56. doi: 10.1111/j.1478-3231.2008.01963.x. Epub 2008 Dec 24.

PMID:
19141026

Supplemental Content

Support Center